Egetis Therapeutics AB (publ) (STO:EGTX)
4.355
-0.115 (-2.57%)
Jan 21, 2026, 12:49 PM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 1.77 billion as of January 21, 2026. Its market cap has decreased by -29.76% in one year.
Market Cap
1.77B
Enterprise Value
1.71B
Revenue
55.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.36
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 1.77B, an increase of 685.44%. That is a compound annual growth rate of 14.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.77B | -16.29% |
| Dec 30, 2025 | 2.11B | -16.09% |
| Dec 30, 2024 | 2.51B | 54.03% |
| Dec 29, 2023 | 1.63B | 7.15% |
| Dec 30, 2022 | 1.52B | 37.56% |
| Dec 30, 2021 | 1.11B | -10.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 41.24B |
| Medicover AB | 31.93B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |